These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures. Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455 [TBL] [Abstract][Full Text] [Related]
8. Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. Jiang L; Han X; Qiu W; Yu T; Feng R; Wang X; Duan X; Deng GM Front Immunol; 2022; 13():824008. PubMed ID: 35273604 [TBL] [Abstract][Full Text] [Related]
9. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report. Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917 [TBL] [Abstract][Full Text] [Related]
10. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D Front Immunol; 2018; 9():322. PubMed ID: 29545790 [TBL] [Abstract][Full Text] [Related]
11. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus. Mina R; Abulaban K; Klein-Gitelman MS; Eberhard BA; Ardoin SP; Singer N; Onel K; Tucker L; O'neil K; Wright T; Brooks E; Rouster-Stevens K; Jung L; Imundo L; Rovin B; Witte D; Ying J; Brunner HI Arthritis Care Res (Hoboken); 2016 Feb; 68(2):195-202. PubMed ID: 26213987 [TBL] [Abstract][Full Text] [Related]
14. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Duits AJ; Bootsma H; Derksen RH; Spronk PE; Kater L; Kallenberg CG; Capel PJ; Westerdaal NA; Spierenburg GT; Gmelig-Meyling FH Arthritis Rheum; 1995 Dec; 38(12):1832-6. PubMed ID: 8849356 [TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis. Sabry A; Sheashaa H; El-Husseini A; El-Dahshan K; Abdel-Rahim M; Elbasyouni SR Clin Rheumatol; 2007 Nov; 26(11):1819-23. PubMed ID: 17340048 [TBL] [Abstract][Full Text] [Related]
16. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus. Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260 [TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus. Mak A; Cheung BM; Mok CC; Leung R; Lau CS Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522 [TBL] [Abstract][Full Text] [Related]
18. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Oates JC; Shaftman SR; Self SE; Gilkeson GS Arthritis Rheum; 2008 Jan; 58(1):263-72. PubMed ID: 18163495 [TBL] [Abstract][Full Text] [Related]
19. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
20. Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus. Kikuchi-Taura A; Yura A; Tsuji S; Ohshima S; Kitatoube A; Shimizu T; Nii T; Katayama M; Teshigawara S; Yoshimura M; Kudo-Tanaka E; Harada Y; Matsushita M; Hashimoto J; Saeki Y Lupus; 2015 Sep; 24(10):1076-80. PubMed ID: 25804673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]